Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;23(22):9857-9862.
doi: 10.26355/eurrev_201911_19549.

Long non-coding RNA XIST promotes hepatocellular carcinoma progression by sponging miR-200b-3p

Affiliations
Free article

Long non-coding RNA XIST promotes hepatocellular carcinoma progression by sponging miR-200b-3p

W-G Liu et al. Eur Rev Med Pharmacol Sci. 2019 Nov.
Free article

Expression of concern in

  • Expression of Concern.
    Authors Listed N. Authors Listed N. Eur Rev Med Pharmacol Sci. 2025 Jun;29(6):287-288. doi: 10.26355/eurrev_202506_37270. Eur Rev Med Pharmacol Sci. 2025. PMID: 40613620

Abstract

Objective: Recent studies have proved that long noncoding RNAs (lncRNAs) act as an important role in many diseases. In this research, lncRNA XIST was explored to identify how it functions in the development of hepatocellular carcinoma (HCC).

Patients and methods: Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) was utilized to detect XIST expression in HCC patients. Then, we conducted Cell Counting Kit-8 (CCK-8) assay and colony formation assays in vitro. Furthermore, mechanism assays and the interaction between XIST and miR-200b-3p were conducted.

Results: By comparing with XIST expression in adjacent tissues, the XIST expression level was significantly higher in HCC samples. Moreover, functional assays showed that the cell growth ability of HCC cells was inhibited after XIST was silenced in vitro, and tumor formation was inhibited after XIST was silenced in vivo. Further experiments showed that miR-200b-3p was directly targeted by XIST.

Conclusions: Above results suggest that XIST could enhance the cell growth ability of HCC by targeting miR-200b-3p, which suggest that XIST may be a potential therapeutic target in HCC.

PubMed Disclaimer